Skip to content
Open access

Prevalence and clinical correlates of autoimmune and infection-related antibodies in unexplained seizures in western China

Jul 2026 · BMC Immunology · Vol 27 · 0 citations · 43 references
Medicine

TL;DR

Combined detection of neural autoantibodies, systemic autoimmune antibodies, and infection-related serological markers facilitates etiological diagnosis and identification of candidates for early immunotherapy in patients with unexplained seizures in western China.

Abstract

Unexplained seizures represent a substantial diagnostic and therapeutic challenge in clinical neurology. Immune-mediated mechanisms coupled with prior infections are increasingly recognized as pivotal etiological contributors, yet large-scale epidemiological data from western China remain scarce. This retrospective cohort study enrolled 471 patients with unexplained seizures from eight provinces in western China between January 2017 and June 2022. Serum and cerebrospinal fluid samples were tested for neural-specific autoantibodies, thyroid peroxidase antibody (TPO-Ab), thyroglobulin antibody (TgAb), antinuclear antibody (ANA), and immunoglobulin M/G antibodies against Toxoplasma gondii, rubella virus, cytomegalovirus, and herpes simplex virus. Patients were stratified into definite autoimmune-associated seizures (AAS), probable AAS, and non-AAS subgroups. This trial was registered with the Chinese Clinical Trial Registry (ChiCTR1900027074) on October 30, 2019, and was retrospectively registered as the first participant was enrolled in January 2017. Overall, 14.65% of patients tested positive for neural-specific autoantibodies, with N-methyl-D-aspartate receptor antibody (NMDAR-Ab) being the most prevalent subtype (accounting for 46.38% of antibody-positive patients), and leucine-rich glioma-inactivated 1 antibody (LGI1-Ab) predominantly detected in patients with recurrent seizures. The positive rates of TPO-Ab, TgAb, and ANA were significantly higher in the definite AAS group than in the non-AAS group (all P < 0.01). No significant differences in pathogen-specific IgM levels were observed among subgroups, while serum HSV-IgG and T. gondii-IgG levels were markedly lower in the non-AAS group (both P < 0.0001). CSF white blood cell count was significantly elevated in the definite AAS group (P = 0.036). Combined detection of neural autoantibodies, systemic autoimmune antibodies, and infection-related serological markers facilitates etiological diagnosis and identification of candidates for early immunotherapy in patients with unexplained seizures in western China.

Read PDF

Similar papers

Review Jun 2026

Prognostic Outcomes in Seropositive and Seronegative Autoimmune Encephalitis

Objectives: Autoimmune Encephalitis (AE) is an immune-mediated inflammatory disorder of the central nervous system with heterogeneous clinical manifestations and variable outcomes. The prognostic significance of antibody status (seropositive vs. seronegative) remains incompletely understood, particularly in Iranian pop...

Mohammad Vafaee-Shahi, Azita Tavasoli, Maryam Kachuei et al. · 0 citations
Open access Aug 2026

Total cerebrospinal fluid IgA as a candidate adjunctive biomarker associated with autoimmune encephalitis: a retrospective case–control study

Background Autoimmune encephalitis (AE) is a rare but severe immune-mediated disease of the central nervous system. Early diagnosis remains challenging, and total cerebrospinal fluid (CSF) IgA is a routinely measurable parameter. However, its association with AE and its potential value as a candidate adjunctive biomark...

Dong-Xing Wang, Ling Tan, Peng-Zhu Yang et al. · 0 citations
Open access Sep 2026

Clinical characteristics and exploratory factors associated with in-hospital mortality in pediatric severe viral encephalitis

Objective The aim of this study was to describe the clinical characteristics of severe viral encephalitis (SVE) in children and to identify exploratory factors associated with in-hospital mortality, thereby providing preliminary evidence to facilitate early risk stratification and reduce SVE-related disability and mort...

P. He, Fang-Qi Hu, Fei Wang · 0 citations
Sep 2026

Clinical Features, Risk Factors, and Outcomes of Pediatric Acute Encephalitis: A Retrospective Cohort Study From 2018 to 2024.

BACKGROUND Early diagnosis of infectious versus autoimmune encephalitis in children is critical for optimizing patient care. METHODS We performed a retrospective cohort study of children one to <18 years of age who had magnetic resonance imaging (MRI) reports with key words "encephalitis" or "meningoencephalitis" at...

Amy Bohling, A. Tippett, Morgan Morris et al. · 0 citations
Open access Sep 2026

Peripheral Inflammatory Biomarkers in Chronic Autoimmune-Associated Epilepsy: An Exploratory Case–Control Study

Lower plasma IL-12 levels may reflect a peripheral immune association in chronic AAE, and this findings are exploratory and hypothesis-generating and require replication in larger, prospectively recruited, independent cohorts.

Laura Serrano-Aguilar, Cristina Fernandez-Hombrados, Mercedes Jimenez-Vargas et al. · 0 citations
Open access Sep 2026

Clinical and pathological significance of serum anti-PD-1 autoantibodies in acute-onset and chronic autoimmune hepatitis.

BACKGROUND Acute-onset autoimmune hepatitis (A-AIH) poses diagnostic challenges because autoantibodies are frequently absent or serum IgG levels may only be mildly elevated. Autoantibodies against the immune checkpoint molecule PD-1 have been detected in patients with chronic AIH (C-AIH). To clarify the clinical and pa...

Takashi Oda, A. Takaki, K. Harada et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.